A study released today in the New England Journal of Medicine finding a "small" risk of thigh bone fractures for patients taking popular osteoporosis drugs concurs with recommendations from a September 2010 Task Force Report of the American Society for Bone and Mineral Research (ASBMR). Last year's Task Force report, which was published in the Journal of Bone and Mineral Research, looked at long-term use of bisphosphonates, concluding that while they prevent many common fractures, the drugs may be related to "atypical femur fractures" when used for more than five years...
No comments:
Post a Comment